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2SUMMARY1
The xylanase Xys1L from Streptomyces halstedii JM8 is processed extracellularly, to2
produce a protein of 33.7 kDa, Xys1S that retains catalytic activity but not its cellulose-3
binding capacity (Ruiz Arribas et l. Appl. Environ. Microbiol. 1997, 63:2983-2988). Here,4
we demonstrate that at least five serine proteases isolated from Strep omyceshave the ability5
to process the xylanase Xys1L. The genes of two of these extracellular serine proteases,6
denominated SpB and SpC, were cloned from S. lividans 66 (a strain commonly used as a7
host for protein secretion), sequenced, and overexpressed in S. lividans, a d both purified8
proteases were able to process Xys1L in vitro. Three other previously reported St eptomyces9
purified serine proteases, -SAM-P20, SAM-P26 and SAM-P45- also processed Xys1L in10
vitro. The involvement of serine proteases in xylanase processing-degradation in vivo was11
demonstrated by co-expression of the xylanase gene (xysA) and the gene coding for the12
serine protease inhibitor (SLPI) from S. lividans. Co-expression prevented processing and13
degradation of Xys1L and resulted in a three-fold increase in the xylanase activity present in14
the culture supernatant. SpB and SpC have also the capacity to process other secreted15
proteins such as p40, a cellulose-binding protein from S. halstedii JM8, but do not have any16
clear effect on other secreted proteins such as amylase (Amy) from S. griseus and xylanase17
Xys30 from S. avermitilis.18
3 INTRODUCTION1
The normal habitat of actinomycetes is soil, where they develop in mycelial form. Their2
ability to thrive in this habitat is based on their nutritional capabilities, conferred by a3
plethora of hydrolytic enzymes that allow them to recycle polysaccharides, proteins and fats,4
and hence, essentially all animal and plant residues. Microorganisms belonging to the genus5
Streptomyces are the most abundant representatives of this group and have a complex life6
cycle that responds to several signals, among which nutrient limitation plays a key role. In7
general, all nutrient effects are observable at morphological level, in which the onset of8
aerial mycelium formation coincides with both the induction of the lysis of substrate hyphae9
by different types of enzymes and with the production of antibiotics. (Champness, 1988;10
Chater, 1989; Hodgson, 2000). Carbon source accessibility can repress or trigger the11
expression of many genes, most of them involved in the hydrolysis of polysaccharides,12
although others, such as those coding for proteases (Ellaiah & Srinivasulu, 1996; Sampath &13
Chandrakasan, 1998) and even the genes involved in antibiotic production, are also affected14
(Bhatnagar et al., 1988; Kojima et al., 1995).15
Xylan, the main component of hemicellulose, is one of the most abundant polysaccharides in16
soil and is totally or partially degraded by a wide number of eukaryotic and prokaryotic17
organisms that need several types of enzymes to achieve total degradation. Endoxylanases18
(EC 3.2.1.8) have attracted industrial interest due to their potential applications in very19
different fields, such as biobleaching of Kraft paper pulps (Bajpai, 1999; Beg et al., 2000)20
and as an additive in animal feeding (Bajpai, 1999; Beg, et al., 2000). Glycoside hydrolases21
have been classified in 90 families by Henrissat et al (http://afmb.cnrs-22
mrs.fr/CAZY/index.html) and all the endoxylanases had been included in families 10 and 1123
until the recent inclusion of a xylanase from Pseudoalteromonas haloplanktis i  family 824
(Collins et al., 2002). Xylanases are most often multidomain enzymes containing one or25
more catalytic domains and a non-catalytic domain, usually a carbohydrate-binding domain,26
4connected to the catalytic domain by a flexible linker region rich in proline, glycine  and1
hydroxyamino acids. The role of these linker sequences is unclear and some authors have2
reported that, together with the carbohydrate-binding domain, they play an important role in3
the activity of xylanases against complex substrates (Black et al., 1997).4
Proteolytic processing of actinomycete cellulases and xylanases has been reported  (Gilkes5
et al., 1988; Lao & Wilson, 1996; Moorman et l., 1993; Ruiz-Arribas et al., 1997) and6
generally, the substrate-binding domain is removed from the original protein to release a7
functional catalytic monodomain enzyme (Gilkes, et al., 1988; Ruiz-Arribas, et al., 1997). A8
putative metalloprotease has been described as being involved in the processing of S.9
reticulii cellulase (Moorman, et al., 1993) and a serine protease has been cloned and studied10
in Thermobifida fusca as implicated in cellulase processing (Lao & Wilson, 1996). The latter11
is a member of the chymotrypsin family and is synthesized as a pre-pro protein of 37512
amino acids that is cleaved to produce the 194-residue mature protease. Although13
proteolysis is not necessary for the activation of cellulases or xylanases, the existence of a14
free form of the enzyme may facilitate the hydrolysis of soluble oligosaccharides.15
The gene xysA from Streptomyces halstedii JM8 encodes a protein of 45 kDa (Xys1L) that is16
processed extracellularly, producing a protein of 33.7 kDa (Xys1S) after removal of a17
cellulose-binding domain at the carboxy terminus of Xys1L. However, proteins Xys1L and18
Xys1S have similar specific activities against xylan (Ruiz-Arribas, et al., 1997). Here we19
show that this proteolysis, which occurs in all Streptomyces strains used as hosts, is mainly20
carried out by serine proteases. We cloned the genes corresponding to two of these serine21
proteases from S. lividans 66, a strain used in most of our expression experiments, and here22
demonstrate the role of both proteases in the processing of Xys1L and other extracellular23
proteins.  We also demonstrate the in vivo role of serine proteases in protein processing by24
co-expression of a serine protease inhibitor and xysA ge es.25
5MATERIALS AND METHODS1
Bacterial strains and plasmids. S. lividans 66 or its derivative S. lividans 3-10 (see below)2
were used in all cloning experiments carried out in Streptomyces. E cherichia coli DH5a3
was routinely used for sub-cloning and isolation of plasmids.4
The xysA gene was obtained from Streptomyces halstedii JM8 (Ruiz-Arribas, et al., 1997)5
and expressed in S. lividans 66 using plasmid pJM9 (Ruiz-Arribas et al., 1995). All plasmids6
used are indicated in Table 1.7
Media and culture conditions. E. coli was grown in Luria Broth (LB) at 37 °C,8
supplemented with ampicillin (100 µg/ml) or kanamycin (50 µg/ml) when needed. R2YE9
and Mannitol soya flour medium (MS) agar plates were used for Streptomyces growth and10
sporulation (Kieser et al., 2000). Submerged cultures of Streptomyces were grown in YES11
medium (yeast extract 0.5 %; sucrose 10.3 %; 5 mM MgCl2, pH 7) (Ruiz-Arribas, et al.,12
1995) supplemented with 1 % xylose. These cultures were grown in baffled flasks with 1/1013
volume of medium. 5-10 µg Thiostrepton ml-1 or 15 µg Neomycin ml-1 was added when14
necessary. Cells were grown at 28 °C and 250 rpm in an orbital shaker (Adolf Kühner AG,15
Birsfelden, Switzerland) for as long as required for each assay (2-5 days).16
DNA manipulations and transformations. Streptomyces total genomic and plasmid DNA17
was obtained as described in Kieser et al (2000) S. lividans protoplasts were obtained from18
cells grown for 30 hours in YEG (1 % Yeast Extract, 1 % glucose, 10,3 % sucrose pH 7)19
supplemented with 5 mM MgCl2 and 0.5 % glycine. Manipulation of E. c liDNA was20
accomplished as indicated by Sambrook et al (Sambrook et al., 1989).21
Cloning of the genes encoding the S. lividans proteases SpB and SpC. The complete22
ORFs of both protease genes were amplified by PCR using oligonucleotides based on S.23
coelicolor sequences. For the equivalent gene to S. coelicolor protease SCF43A.19,24
oligonucleotides VR017 (5’-tttttttcatATGGTCGGCAGACACGCCGCC-3’) and VR018 (5’-25
tattatcTCGAGGACCCGCTGCCACAGGGCCGG-3’) were used. For the equivalent gene to26
6S. coelicolor protease SCD40A.16c, oligonucleotides VR019 (5’-1
tttttttcatATGCCCCACCGACACCGACAC-3’) and VR020 (5’-2
tattatcTCGAGCACTCGCTGCCACAGCGCCGG-3’) were used. The underlined parts3
indicate the sequences for an NdeI site (oligonucleotides VR017 and VR019) and a XhoI site4
(oligonucleotides VR018 and VR020) that were added to facilitate the cloning steps. The5
capital letters represent the complementary sequences to SCF43A.19 (oligonucleotides6
VR017 and VR018) and SCD40A.16c (oligonucleotides VR019 and VR020). Amplification7
was carried out in a MJ Research thermocycler with Taq Polymerase (Dynazyme), 1.5 mM8
MgCl2 and 100 ng of genomic S. lividans as template. Cycling conditions were: 5 min at 949
°C, “Hot Start” and 31 cycles of 1 min at 94 °C, 1 min at 60 °C, 1 min at 72 °C; final10
extension at 72 °C for 10 min. The PCR products (1.4 kb) were purified by agarose gel11
electrophoresis, digested with NdeI and XhoI, and cloned in pET22b(+) (under ampicillin12
selection and with E. coli DH5a  as host).13
The same amplicons were cloned under control of the xysA promoter and were flanked by14
mmrt and fdt transcriptional terminators using the E. coli/Streptomyces shuttle vector15
pN702GEM3. The plasmids obtained -pVR047 and pVR048 respectively (Table 1)- were16
transformed into S. lividans 66 and S. lividans 3.10 for protease expression.17
DNA sequencing. The DNA sequences were determined in both strands using a Perkin18
Elmer ABI Prism 377 DNA sequencer. Several oligonucleotides designed from the DNA19
sequences collected were used to obtain the definitive DNA sequence. Manipulation was20
done with the Gene Construction Kit™ (GCK) and analyses were made with DNA Strider21
(Marck, 1988). Comparisons of DNA or protein sequences were carried out on-line22
(http://www2.ebi.ac.uk/) with FASTA (Pearson & Lipman, 1988) and BLAST (Altschul et23
al., 1997). CLUSTAL W (Thompson et al., 1994) was used for sequence alignment.24
The sequences of the genes of both proteases have been deposited in the EMBL Data Bank25
with the following accession numbers AJ496191 and AJ496192.26
7Isolation of serine protease inhibitor-deficient strains. Serine protease inhibitor-deficient1
strains (SLPI-) were obtained from S. lividans 66 following the observations of Taguchi et2
al. in the case of S. albogriseolus (Taguchi et al., 1995 a). This author reported that SLPI-3
strains were obtained at high frequency after protoplast regeneration due to the gene4
encoding this protein being located close to the end of the linear chromosome which5
undergoes frequent deletions (Kuramoto et al., 1996). After S. lividans protoplast cell wall6
regeneration, colonies defective in differentiation were selected and protease overproduction7
was studied in plates containing 0.5 % skimmed milk. The putative SLPI- str ins were later8
corroborated by immunodetection, using anti-SLPI polyclonal antibodies. One of the strains9
obtained was denominated S. lividans 3.10.10
Antibody generation and immunodetection The synthetic peptide11
RAVTLTCAPTASGTHP derived from the Streptomyces lividans protease inhibitor12
sequence (SLPI) (Accession Number M80576) was obtained from Chiron Technologies and13
was inoculated into two rabbits to obtain polyclonal antibodies. Immunodetection was14
performed on proteins transferred to Immobilon-P membranes  (Millipore) with anti-rabbit15
alkaline phosphatase-conjugated antibodies (Promega). A 1/25000 dilution of the16
antipeptide antiserum was used.17
Protein purification. S. lividans 66 transformed with pVR052 (Table 1) was used for S.18
lividans protease inhibitor (SLPI) production. S lividans 3.10, a serine protease inhibitor-19
deficient strain transformed with pVR047 or pVR048 (Table 1), was used to obtain the20
proteases SpB and SpC, respectively. Two liters of YES supplemented with 1 % xylose and21
15 µg/ml of neomycin were inoculated with 200 ml of a culture of the corresponding strain,22
which had been grown in the same medium for 36 h and subsequently divided into 500 ml23
aliquots in 2-liter baffled flasks. Incubation on a rotary shaker was continued at 28 °C for 524
days. The supernatants were filtered through 0.45 µm membranes, concentrated 30 times in25
8a Minitan cell (Millipore) equipped with a 10 kDa cut-off polysulfone membrane, and1
diafiltered with 20 mM Tris-HCl, pH 7.2 or with MilliQ water.2
Chromatographic procedures were performed with an ÄKTA Purifier system controlled by3
Unicorn®.-3.1 software (Amersham Pharmacia Biotech). Absorbance was monitored at 2804
nm and 205 nm.5
For SLPI inhibitor purification, the concentrated supernatant was equilibrated with 20 mM6
Tris-HCl buffer, pH 7.2, loaded into a MonoQ (HR 5/5 anion exchange) column (Pharmacia7
Fine Chemicals) equilibrated with the same buffer, and eluted with a 0–0.4 M NaCl gradient8
in the same buffer at a flow rate of 1 ml/min. The purified inhibitor eluted as a major peak at9
0.11 M NaCl.10
For SpB protease purification, the concentrated sample was equilibrated with 10 mM11
NaOAc buffer, pH 5.0, and loaded into a MonoQ column equilibrated with the same buffer.12
The protein was eluted with a 0-0.84 M NaOAc gradient in the same buffer at a flow rate of13
1 ml/min. Fractions from the anionic exchange column showing biological activity (eluting14
between 0.52-0.73 M NaOAc) were pooled, concentrated in Centricon Plus-20 devices15
equipped with 10 kDa Molecular Weight Cut Off (MWCO) membranes, and diafiltered with16
20 mM phosphate buffer, pH 7.2. 1.7 M ammonium sulphate (final concentration) was17
added prior to loading into a Phenyl-Superose column (HR 5/5 hydrophobic interaction18
column; Pharmacia Fine Chemicals) equilibrated with the same buffer. Elution was19
accomplished at a flow rate of 1 ml min-1, with a decreasing-step gradient from 1.7-0.85 M20
ammonium sulphate in 2 ml; followed by 0.85-0,68 M ammonium sulphate in 15 ml. The21
xylanase-processing fractions (eluting between 0.80-0.73 M) were pooled and concentrated22
15-fold in Centricon Plus-20 devices equipped with 10 kDa MWCO membranes. Aliquots of23
500 µl were loaded, at a flow rate of 0.1 ml/min, into a Superdex-75B column (HR 10/30 gel24
filtration column; Pharmacia Fine Chemicals), equilibrated in PBS, pH 6.8. The active25
9fractions (eluting at 11.687 mL; approx MW 29 kDa) were pooled to afford homogeneous1
preparations of a single protein.2
For protease SpC, the concentrated supernatant was equilibrated with 20 mM Tris-HCl3
buffer, pH 7.7, and loaded into a MonoQ column equilibrated with the same buffer. The4
protease was eluted with a 0-0.3 M NaCl gradient in the same buffer. Fractions from the5
anionic exchange column showing biological activity (eluting between 0.15-0.22 M NaCl)6
were pooled, concentrated in Centricon Plus-20 devices equipped with 10 kDa MWCO7
membranes, and diafiltered with 20 mM Phosphate buffer pH 7,2.8
The purity of all different proteins was checked in silver-stained SDS-PAGE (Morrisey,9
1981). The amino-terminal end of all of the proteins was determined using an Applied10
Biosystems Protein Sequenator.11
Protein analysis and enzyme assays. Protein concentrations were determined using the12
method of Peterson (Peterson, 1977). Electrophoresis in denaturing polyacrylamide gels13
(SDS-PAGE) was performed as described elsewhere (Ruiz-Arribas, et al., 1995). Detection14
of proteolytic activity (zymogram analysis) was performed after electrophoresis in 15 %15
acrylamide SDS-PAGE containing 0.2 % gelatin (Sigma) or 0.2 % skimmed milk (Sveltesse,16
Nestlé) included in the separating gel.  The samples were mixed with the loading buffer and17
heated for 15 min at 50 °C. After electrophoresis, the gel was rinsed several times in MilliQ18
water and washed for 30 min in 2.5 % TritonX-100 followed by a 30 min wash in 0.2 M19
NaPO4, pH 7. The gel was incubated for 2-4 hours at 45 °C in the same buffer and then20
stained with 0.5 % Coomassie Brilliant Blue R. Clear bands corresponding to proteolytic21
activity were observed after destaining.22
Protease activity on Xys1L was studied in an in vitro experiment in which Xys1L23
(supernatants containing either Xys1L or pure protein) was mixed with the filtered24
supernatant containing the protease or with pure protease solution and incubated for25
different periods of time at 37 °C. Typically, 4 µg of pure Xys1L and 0.25-1 µg of pure26
10
proteases were tested in each assay at a final volume of 30 µL. When total supernatants were1
used as the source of protease, 6 µg of total protein was used. The effect of chemical2
protease inhibitors was tested in this type of assay at the concentrations and under the3
conditions described in the literature. (Díaz-Rodríguez et al., 1999). The inhibitors assayed4
were: 50-150 µM N-Acetyl-Leu-Leu-Met-al (ALLM); 50-150 µM N-Acetyl-Leu-Leu-5
Norleucinal (ALLN); 10-30 µg aprotinin ml-1; 1-30 mM ethylenediaminetetraacetic acid6
(EDTA); 1-30 mM ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid7
(EGTA); 1-5 mM 1,10-phenanthroline; 10-50 µM fosforamidon; 10-50 µg leupeptin ml-1; 2-8
10 µM pepstatin; 1-2 mM phenylmethylsulfonyl fluoride (PMSF); 10-30 µg soybean trypsin9
inhibitor (STI) ml-1; 5-15 mM Na -p-tosyl-L-arginine methyl ester hydrochloride (TAME);10
10-100 µM Na -p-tosyl-L-lysine chloromethyl ketone hydrochloride (TLCK); 25-100 µM11
iodoacetic acid.12
The effect of the pure S. lividans proteinaceous serine protease inhibitor subtilisin type SLPI13
was also studied at concentrations varying between 0.02 and 1 µg.14
Xylanase activity was measured in culture supernatants by the dinitrosalicylic acid (DNS)15
method, using xylose as standard (Bernfeld, 1951; Biely et al., 1985). One unit of enzyme16
activity was defined as the amount of enzyme required to release 1 µmol of reducing sugars17
(expressed as xylose equivalents) over one minute.18
Enzymes and reagents were purchased from Boehringer Mannheim, Promega, Bethesda19
Research Laboratories, Pharmacia, Sigma, Merck, Panreac, Bio-Rad, Santa Cruz and20
Ambion, and were used following the manufacturers' guidelines.21
11
RESULTS1
Extracellular serine proteases process the Xylanase Xys1L. The processing of Xys1L to2
produce Xys1S was mainly observed in aged cultures (older than 48 h) of the original strain3
S. halstedii JM8 and in all the Streptomyces strains used as heterologous hosts: S. lividans4
66, S. albus J1074 and S. parvulus JI2283 (Ruiz-Arribas, et al., 1995). An in vitro5
experiment was developed as follows: the filtered supernatant from a 48 hour culture of S.6
lividans 66 bearing plasmid pJM9, which permits overexpression of xylanase Xys1L, was7
incubated at 37 ºC for 1-3 hours in the presence of S. halstedii JM8 filtered supernatant. The8
processing of Xys1L to originate Xys1S increased with the incubation time and non-specific9
degradation of Xys1S was also observed after longer incubations (3 h, Fig. 1a). These10
processing-degradation events were not observed when the S. halstedii JM8 supernatant had11
been previously boiled for 5 minutes (Fig. 1a). The results of this experiment demonstrated12
the presence of extracellular thermolabile protease/s responsible for the processing-13
degradation observed. A similar effect was observed with all supernatants from all he14
Streptomyces strains tested (data not shown).15
The effect of different chemical protease inhibitors (Materials and Methods) was16
studied in the same type of in vitro processing assay. Only PMSF, a serine protease17
inhibitor, elicited partial inhibition of the protease(s), (Fig. 1b). Inhibitors for other types of18
proteases, such as metalloproteases (EDTA, EGTA), aspartyl proteases (pepstatin) and19
cysteine proteases (iodoacetic acid), did not show any effect. From these results, we20
concluded that the main proteases involved in this process belong to the serine proteases21
group.22
Effect of proteinaceous serine protease inhibitor (subtilisin type) on the processing of23
Xys1L. Since S. lividans 66 is a commonly used laboratory host strain for xylanase gene24
(xysA) overexpression, we studied Xys1L processing when it was produced in this host.25
Xylanase processing in S. lividans occurs at the same position (after D362) (Ruiz-Arribas, et26
12
al., 1997) as in the original S. halstedii strain, suggesting the presence ofat least a number of1
similar proteases in both strains. In vitro experiments confirmed that the four-day old filtered2
culture of S. lividans 66 was also able to process Xys1L. Nevertheless, a longer incubation3
time was required (as compared to S. halstedii JM8 supernatants) and only long incubation4
times (6 h) afforded total processing of Xys1L. PMSF-induced inhibition of processing was5
also observed, again suggesting that extracellular serine proteases were involved (data not6
shown).7
Since most members of the genus Streptomyces are a good source of proteinaceous serine8
protease inhibitors (Taguchi et al., 1993; Taguchi et al., 1997), we decided to study the9
effect of the subtilisin-type inhibitor (SLPI) from S. lividans on the processing of Xys1L.10
First, twenty putative S. lividans SLPI-defective strains were obtained following the method11
of Taguchi et al. (Materials and Methods); it was observed that most of them were also12
subject to growth problems in complex media. Two of these strains (named 3.1 and 3.10)13
were selected and the absence of SLPI was corroborated by Western blot analysis with anti-14
SLPI antisera (Fig. 2a). In vitro experiments of Xys1L processing confirmed that the15
supernatant from these strains processed Xys1L more efficiently than the S. ividans w16
strain, suggesting that the activity of the proteases responsible was somehow blocked by the17
inhibitor (Fig. 2b).18
In order to overproduce the SLPI protein, its corresponding gene (Accession Number19
M80576) was amplified with two oligonucleotides designed to clone the complete ORF20
(with its own RBS) under control of the xylanase sA promoter (Ruiz-Arribas, et al., 1997)21
in order to obtain plasmid pVR052 (Table 1). This promoter is induced by xylose or xylan22
and is repressed by glucose and has proved to be a very efficient promoter for homologous23
and heterologous gene expression in Streptomyces (Díaz et al., unpublished). The production24
of SLPI was accomplished as indicated in Materials and Methods and the protein was25
partially purified (up to 99 %). The effect of SLPI was studied in in vitro experiments in26
13
which pure Xys1L (Ruiz-Arribas, et al., 1997) was incubated with the filtered supernatant1
from S. lividans 66 and different amounts (1-10 µg) of the purified protease inhibitor. The2
presence of inhibitor partially reduced the processing of Xys1L (data not shown). Therefore,3
proteinaceous subtilisin serine protease inhibitors  partialy inhibit the serine proteases4
responsible for Xys1L processing.5
Coexpression of xylanase and protease inhibitor genes increase xylanase production.6
The effect of co-expressing the xylanase gene (xysA) and the gene that encodes the protease7
inhibitor SLPI (slpI) was also studied. A transcriptional fusion in which the xysA promoter8
controls the expression of both genes - xysA and slpI- was constructed. This fusion was9
cloned into the bifunctional plasmid pN702GEM3 (Table 1) flanked by transcriptional10
terminators to obtain plasmid pVR011 (Table 1 and Fig. 2c). As a control, the same vector11
containing only the xysA gene (plasmid pNAMP7) was used. The supernatants from several12
independent clones were analyzed by SDS-PAGE and their xylanase activity was measured.13
The positive effect of co-expressing both genes as compared to the results corresponding to14
cultures expressing only the xysA gene was observable at two levels: 1) a reduction in15
xylanase Xys1L processing, and 2) an increase in the amount of xylanase produced, (Fig.16
2d). Xylanase activity measurements revealed that the supernatants co-expressing xy A and17
slpI displayed three-fold more xylanase activity (480 U ml-1) than those expressing xysA18
alone (150 U ml-1). Therefore, this inhibitor has two positive effects that should yield a19
higher total amount of xylanase, first by blocking Xys1L processing to produce Xys1S, and20
then by reducing the proteolysis-degradation undergone by this protein.21
Cloning of two serine proteases from S. lividans involved in Xys1L processing. The role22
of a serine protease in the processing of cellulases has been described in Thermomonospora23
fusca (now Thermobifida fusca), where the protease encoded by the tfpA gene cleaves its24
cellulases into many different isoenzymes (Calza et al., 1985; Lao & Wilson, 1996). A25
BLAST search (Altschul, et al., 1997) with the sequence of this protease (Accession26
14
Number O86984) against the S. coelicolor data bank1
(http://www.sanger.ac.uk/Projects/S_coelicolor/) detected two different ORFs with clear2
similarity: ORF SCF43A.19 (Accession Number Q9XA96) shows 45 % identity (58 %3
similarity), and ORF SCD40A.16c (Accession Number Q9L0J5), which has 46 % identity4
(59 % similarity). Two oligonucleotides were designed for each gene (see Materials and5
Methods) and both ORFs were amplified by PCR from S. lividans 66 genome and cloned in6
pET22b(+). The complete DNA sequences of these ORFs were obtained and compared with7
the S. coelicolor Data Bank. The proteases encoded by S. lividans genes were denominated8
SpB (similar to SCF43A.19) and SpC (similar to SCD40A.16c). The SpB ORF is 458 amino9
acids long and is almost identical (99 %) to SCF43A.19 from S. coelicolor, which is also10
458 aa long. Two amino acid changes were observed: one located in residue 75 -L in11
SCF43A.19 and P in SpB,- and another in residue 341, E in SCF43A.19 and G in SpB. Only12
this latter change is present in the mature protein (see below). SpC is also 458 aa long and its13
homologue (98 %) in S. coelicolor is SCD40A.16c (463 aa). The changes observed between14
both ORFs are residue 66, L in SCD40A.16c and I in SpC; residue 122, I in SCD40A.16c15
and V in SpC; residue 244, G in SCD40A.16c and D in SpC, and residue 377, E in16
SCD40A.16c and G in SpC. The most significant change is a five amino acid deletion17
between residues 409 and 413, corresponding to the amino acid repeat GDDGG that is18
present three times in S. coelicolor SCD40A.16c and only twice in SpC from S. lividans.19
These amino acids are located at a linker region that connects the protease catalytic domain20
with a chitin-binding domain present at the C terminus of all these proteins. That domain is21
47 amino acids long and shows similarity to chitin binding domains present in several22
chitinases. Chitin binding domains in proteases have been previously described for protease23
C from S. griseus (Sidhu et al., 1994).  The complete ORF of this protease shares 55 %24
identity with proteases SpB and SpC.25
15
In order to express both ORFs in S. lividans, they were cloned under control of the xysA1
promoter in the bifunctional plasmid pN702GEM3 to afford plasmids pVR047 and pVR0482
(Table 1), which were transformed into S. l vidans 66 (wt strain) and S. lividans 3.10 (SLPI-3
strain). Protease production in both strains was studied by SDS-PAGE in supernatants from4
several independent clones. No differential bands were detected by Coomassie Blue staining5
when compared to transformants carrying an empty vector. However, several active protease6
bands were detected in zymograms carried out in renatured SDS-PAGE containing gelatin or7
skimmed milk, in which the samples were not boiled. This diversity of active bands was8
identical in both host strains (wt and SLPI-) (data not shown).9
In vitro experiments using filtered supernatants from S. lividans 3.10 transformants10
expressing SpB or SpC confirmed that Xys1L was more efficiently processed by them than11
by the supernatant from the same strain transformed with the empty vector (Fig. 3a).12
Both proteases were purified as indicated in Materials and Methods. Four milligrams of pure13
SpB and five of SpC were obtained from 2 liters of culture. In SDS-PAGE, both proteases14
failed to run according to the sequence-predicted sizes (458 aa), suggesting the existence of15
pre-pro proteins, as is common for this type of protein (Fig. 3b). The N-terminus determined16
for both of them starts in the EDLV sequence in SpB and in the YDLR sequence in SpC. In17
both proteins, the first residue obtained corresponded to residue 207. SDS-PAGE of both18
pure proteins revealed a single band of 31-33 kDa for protease SpB and a band of about 23-19
25 kDa for protease SpC. Zymogram analyses of both pure proteases, in which the samples20
were not boiled, detected several active bands for both of them (Fig. 3c). Zymograms with21
boiled samples did not reveal protease activity (data not shown).22
The observation of in vitro Xys1L processing with SpB or with SpC pure proteases23
demonstrated that both were able to process Xys1L efficiently. However, SpB was more24
active since 0.25 µg of protease sufficed to process 4 µg of Xys1L almost totally after 325
hours of incubation, while 0.50 µg of SpC were required to obtain a similar extent of26
16
processing (Fig. 3d lane 0). Partial biochemical characterization of both proteases was1
accomplished using Xys1L as substrate. Both were more active at 50 °C than at 37 °C (the2
temperature normally used in our in vitro experiments) and the presence of 10 mM CaCl2, or3
10mM MgCl2 in the reaction mixture failed to affect their activity (data not shown). The4
inhibitory effect of pure serine protease inhibitor SLPI (from 0.02 to 1 µg) increased with5
the amount of SLPI added in the experiment and 0.5 µg were sufficient to block the6
processing of Xys1L (Fig. 3d).7
The effect of other inhibitors such as 2 mM PMSF, 30 µg aprotinin ml-1, 30 µg STI ml-1, 1008
µM TLCK, 30 µg leupeptin ml-1, 10 µM pepstatin, 4.5 mM 1,10-phenanthroline and 30 mM9
EDTA were also studied. As expected, both proteases were totally inhibited by PMSF,10
although, SpB was almost totally inhibited by aprotinin while SpC was not. Among the11
other inhibitors studied only leupeptin shows partial inhibition of SpB and does not have any12
clear effect on SpC activity (at the concentration assayed) (Fig. 3e).13
All these experiments demonstrated that both serine proteases are involved in the processing14
of Xys1L and that both respond similarly to the presence of the inhibitors SLPI and PMSF15
but not to the presence of other inhibitors such as aprotinin and leupeptin. These small16
differences in their inhibition profiles suggest that SpB and SpC are similar but not17
absolutely equivalent.18
Other serine proteases from Streptomyces also process Xys1L. Now that the S.coelicolor19
genome has become available, at least 12 proteins have been identified as serine proteases20
by sequence similarity. Some homologues of these proteases have been cloned from21
different Streptomyces strains. Among them, SAM-P20 (Taguchi et al., 1995 b), SAM-P2622
(Taguchi et al., 1998) and SAM-P45 (Suzuki et al., 1997) from S. albogriseolus have been23
studied. Pure enzymes (a SAM-P20 homologous isolated from S. coelicolor Müller, SAM-24
P26 and SAM-P45 from S. albogriseolus), provided by Taguchi, were used to study the25
processing effects on Xys1L in in vitro experiments. All of them were able to process the26
17
xylanase in a similar manner to SpB and SpC (Fig. 4a). Because these three serine proteases1
interact with the subtilisin inhibitor of S. albogriseolus, homologous to the SLPI inhibitor2
from S. lividans, we conducted studies aimed at determining whether pure SLPI might block3
their activity on Xys1L, observing that the proteolytic activity was blocked by the presence4
of this inhibitor.5
Commercial serine proteases from different sources, such as subtilisin A from Bacillus6
licheniformis (SIGMA P5380) and a serine protease from Aspergillus (SIGMA P4032),7
completely and non-specifically degraded the xylanase even after short incubation periods8
and at low protease concentrations (data not shown).9
These results suggest that Xys1L processing is not carried out by a single enzyme but it is,10
instead, susceptible to the action of a variety of St eptomyces serine proteases, which are11
probably produced differentially, depending on the culture conditions.12
Effects of SpB and SpC on the processing of other extracellular proteins. Cu rently, our13
group is also studying the production of other proteins in S. lividans and some of them have14
also been found to undergo post-translational modifications. We therefore tested the effects15
of S. halstedii JM8 supernatant and pure SpB and SpC proteases on the following proteins:16
p40, a protein with no known catalytic activity and with a cellulose binding domain at the17
carboxy terminus, isolated from S. halstediiJM8 (Garda et al., 1997) that is structurally18
similar to the xylanase Xys1L; Amy, an a -amylase from S. griseus IMRU3570 (Vigal et al.,19
1991), and Xys30, a xylanase from S. avermitilis (NCBI AAD32560). In vitro experiments20
were carried out mixing S. lividans upernatants in which each protein of interest had been21
overexpressed with the S. halstedii JM8 supernatant or with pure SpB or SpC proteases. The22
S. halstedii JM8 supernatant was able to process and degrade all the proteins studied. Both23
proteases were able to process p40, producing a protein of 35 kDa that corresponded to the24
formerly named p35 (Garda, et l. 1997). This protein had previously been observed in25
supernatants of aged cultures (older than 48 h) overexpressing the p40 gene and corresponds26
18
to a truncated form in which the CBD has been removed.  A weak partial processing of the1
amylase from S. griseus was observed but no effect on the xylanase Xys30 from S.2
avermitilis was observed when pure SpB or SpC proteases wer  used (Fig. 4b). These results3
clearly indicate that the serine proteases studied are active in the processing and/or4
degradation of extracellular proteins and that their role should be considered when studying5
the overexpression of proteins of interest in Str p omyces hosts.6
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DISCUSSION.1
Proteolysis has been described as the origin of multiple isoenzyme forms in different2
microorganisms (Gilkes, et al., 1988; Lao & Wilson, 1996; Moorman, et al., 1993). In3
cellulases and xylanases, this process normally occurs at the linker region that joins the4
catalytic and the substrate-binding domains and originates free forms of the enzyme able to5
the hydrolyse soluble oligosaccharides generated after a first attack on the substrate.6
In actinomycetes, Moormann et al (1993) described the purification of a 36 kDa7
putative metalloprotease involved in the processing of an 82 kDa avicelase from S. reticuli8
(Cel1) (Moorman, et al., 1993). The protease cleavage site is located at the beginning of the9
catalytic domain of the enzyme and generates two fragments: an amino terminal inactive10
fragment of 40 kDa that contains the cellulose-binding domain, and a carboxy terminal of 4511
kDa that retains the catalytic activity and even exerts increased activity against p-nitro-12
phenyl-ß D-cellobioside (Moorman, et l., 1993). Serine proteases have been reported to be13
involved in the processing of glucanases in two different actinomycetes. Thus, processing of14
the endoglucanase CenA and the exoglucanase Cex from Cellulomonas fimi is carried out by15
the same serine protease that cuts at the linker region of both enzymes (Gilkes, t al., 1988).16
No further investigations concerning this protease have been published and it is therefore not17
possible to compare it with those studied here. The role of serine proteases in the processing18
of cellulases has been documented in T. fusca, for which Lao and Wilson (Lao & Wilson,19
1996) described the cloning and expression of a protease gene (tfpA) in S. lividans. This20
368-amino acid protease, which might be included in the chymotrypsin family, is secreted as21
a pre–pro protein with 194-residues in its mature form. The two genes cloned here encode22
proteases sharing about 45 % identity with the catalytic domain of the T. fusca protease and23
with the S. griseus protease C (Sidhu, et al., 1994).24
Proteases SpB and SpC are encoded as two proteins of 458 amino acids that have putative25
signal peptides at the N-terminus of 31 aa for SpB and 32 aa for SpC, followed by a26
20
propeptide up to amino acid 207, which is eliminated in both cases to produce the mature1
proteins. The sequences around the residue 207 PRVL¯ EDLV for SpB and PRTF¯ YDLR2
for SpC are similar to the processing sequences of S. griseus erine proteases A, B, C and D.3
The putative catalytic triad corresponds to aminoacids H242, D270 and S351, which are4
included in conserved regions, but further investigations would be necessary to confirm their5
role as part of the active center. Both S. lividans proteases (SpB and SpC) and their6
homologues in S. coelicolor have a carboxy terminal domain of 47 amino  acids, similar to7
those of chitin-binding domains present in several chitinases. The presence of this type of8
domain has previously been described in protease C from S. griseus and its putative role was9
explained on the basis of the coexistence of chitin and proteins in insect cuticles. It is10
possible that the efficient degradation of chitin would require the collaboration of proteases11
recruited through their chitin-binding domain (Sidhu, et al., 1994).12
The processing of Xys1L is not exclusive to the proteases SpB and SpC or their13
homologues, depending on the host. Here we observed that another three serine proteases14
isolated from a different strain of Streptomyces, SAM-P20, SAM-P26 and SAM-P45, also15
process Xys1L. All five proteases have homologues in the S. coelicolorgenome, whose16
sequence has recently been completely determined (Bentley et al., 2002). Proteases SpB and17
SpC have almost identical proteins encoded by ORFs SCF43A.19 and SCD40A.16c18
respectively. Protease SAM-P20 is 85 % identical to ORF SCI11.35c; SAM-P26 is 85 %19
identical to SCI11.30c, and SAM-P45 shares 43 % identity with the proteins encoded in20
ORFs SCF51A.10 and SCC24.17c, which have been described as putative secreted21
peptidases. Another eight ORFs in the S. coelicolor genome have been described as putative22
serine proteases: namely, 2SCG61.37c; SCI35.29c; SC8E4A.07; SCH17.01c; SCH5.30;23
SC3C3.08; SC3C3.17c, and SC10G8.13c. The multiplicity of enzymes with overlapping24
activities could be explained in terms of a different expression pattern that permits the25
expression of one or another gene, depending on the growth conditions. In the case of26
21
proteases, the effect of carbon or nitrogen sources on the differential expression of the1
corresponding genes has been described (reviewed in Hodgson, 2000). Study of the2
expression patterns of these ORFs and their role in the processing and degradation of3
overproduced extracellular proteins will be one of our objectives in a forthcoming work.4
Meanwhile, co-expression of serine protease inhibitors together with target proteins might5
be a useful approach in biotechnological applications where a target protein is processed or6
degraded by endogenous proteases of the serine protease family.7
8
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FIGURE LEGENDS1
2
Figure 1. Coomassie Blue-R stained SDS-PAGE of: a.- In vitro processing of Xys1L to3
Xys1S by filtered supernatants of S. halstedii JM8 (S.h. JM8 and S.h. JM8/boiled). XC4
(xylanase control) is the supernatant from a S. lividans train overexpressing Xys1L. This5
sample (XC) was incubated at 37 ºC for 3 h without S. halstedii JM8 supernatant. 6 µg of6
protein were loaded in each lane. Positions of molecular weight markers are indicated at the7
right. b.- Effect of the addition of 1 mM PMSF on the in vitro processing of Xys1L by a8
filtered supernatant of S. halstedii JM8. XC: xylanase control. Samples were incubated at 379
°C for 2 h. 3 µg of protein were loaded in each lane.10
11
Figure 2. a.- Immunodetection of the protease inhibitor (SLPI) in culture supernatants of S12
lividans 66 (S. liv. wt). S. lividans 3.1 and S. lividans 3.10 (S. liv. 3.1 and S. liv. 3.10) are two13
SLPI deficient strains obtained as described in the text. b.- Coomassie Blue-R stained SDS-14
PAGE showing the in vitro processing of Xys1L by a filtered supernatant of the three strains15
to produce Xys1S. XC is the S. lividans upernatant overexpressing Xys1L used in the in16
vitro experiment. Three µg of total protein were loaded in each lane. Incubation was for 3 h17
at 37 ºC. c.- Schematic representation of the construction present in the plasmid pVRO1118
(Table 1). Both ORFs, corresponding to xylanase and inhibitor, are expressed under the19
control of the xylanase promoter (xysAp). T1 and T2 are the mmrt and fdt transcriptional20
terminators respectively. d.- Coomassie Blue-R stained SDS-PAGE showing the proteins21
present in 10 µl of supernatant of S. lividans 66 containing the plasmid pNAMP7, which22
only expresses the xylanase gene, and the same strain containing pVRO11, expressing the23
xylanase and the inhibitor.24
Figure 3.- a.- Coomassie Blue-R stained SDS-PAGE showing the i  vi ro processing of25
Xys1L by filtered supernatant from the three S. lividans 3.10 transformed with vector26
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pN702GEM3 (V), with pVRO47 (SpB) or pVRO48 (SpC). XC is the S. lividansupernatant1
overexpressing Xys1L used in the in vitro experiment. Incubation was carried out at 37 ºC2
for 1h. b.- Coomassie Blue-R stained SDS-PAGE showing the purity of the proteases SpB3
and SpC after the FPLC purification indicated in the text. c.- Protease zymogram on gelatin4
with pure SpB and SpC (sample preparation was not completely denaturing and the activity5
bands give no indication of real molecular weight). d.- Coomassie Blue-R stained SDS-6
PAGE showing the effect of different amounts of SLPI protease inhibitor (from 0 to 1 µg)7
on the in vitro processing of pure xylanase Xys1L (Xys1L) by pure SpB (0.25 µg/assay) or8
pure SpC (0.5 µg/assay). Incubation was carried out for 3 h at 37 ºC. e.- Coomassie Blue-R9
stained SDS-PAGE showing the effect of different protease inhibitors on the processing of10
pure Xys1L by pure proteases SpB (0.25 µg/assay) or SpC (0.5 µg/assay). Control (0) is the11
processing obtained with these proteases without any inhibitor. The inhibitor concentrations12
used were: 2 mM PMSF; 30 µg aprotinin ml-1; 30 µg STI ml-1; 100 µM TLCK; 50 µg13
leupeptin ml-1; 10 µM pepstatin; 4.5 mM 1,10-phenanthroline and 30 mM EDTA. Incubation14
was carried out at 37 ºC for 3 h.15
16
Figure 4. a.- Coomassie Blue-R stained SDS-PAGE showing the i  vi ro processing of17
Xys1L by different Streptomyces proteases. XC is the xylanase control. S.h. JM8 shows the18
processing by the filtered supernatant of the S. halst dii JM8 strain; 3 µg of total protein19
were used. SpB: pure protease from S. lividans. SAM-P20: protease isolated from S.20
coelicolor Müller homologous to SAM-P20 from S. albogriseolus; SAM-P26: protease from21
S. albogriseolus (Taguchi, et al., 1998); SAM-P45: protease from S. albogriseolus (Suzuki,22
et al., 1997). 0.25 µg of the corresponding pure proteases were used in each assay.23
Incubation was carried out for for 3 h at 37 ºC. b.- Coomassie Blue-R stained SDS-PAGE24
showing the in vitro processing-degradation of different secreted proteins, p40 (Garda, et al.,25
1997), Amy (Vigal, et al., 1991) and Xys30 (NCBI AAD32560), by S. lividans SpB and26
31
SpC proteases. XC is the S. lividans upernatant overexpressing the corresponding protein1
used in the in vitro experiment. S h. JM8, is the processing originated by the filtered2
supernatant from this strain, used as a positive control; 3 µg of total protein were used. SpB3
and SpC indicate the processing obtained with 0.25 µg of pure SpB or with 0.5 µg of pure4
SpC. Incubation was carried out for 3 h at 37 ºC.5
6
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Table 1: Plasmids used.
Plasmid Description Reference
pET22b(+) E. coli expression vector, with T7 promoter control and poly-Histidine
tag at the C-terminus of ORFs cloned on it.
Novagen
pJM9 pIJ702 derivative containing the xysA gene as originally cloned from
S. halstedii JM8
(Ruiz-Arribas, et al., 1995)
pN702GEM3 E. coli-Streptomyces shuttle vector. It contains the pIJ702 origin of
replication (for Streptomyces), the bifunctional neo/kan resistance
marker from Tn5 (for both E. coli and Streptomyces), the pUC origin
of replication (for E. coli) and a polylinker derived from pGEM3Zf(+)
(Promega).
This Work
pNAMP7 pN702GEM3 derivative containing the xysA (from S. halstedii JM8)
expressed from its own promoter (xysAp) and flanked by
transcriptional terminators (mmrt and fdt).
This Work
pVR011 pN702GEM3 derivative containing the xysA (from S. halstedii JM8)
and slpI (from S. lividans 66) genes as a transcriptional fusion under
xysAp control. The slpI gene retains its ribosomal binding site. 
expression cassette is flanked by transcriptional terminators (mmrt
fdt).
This Work
pVR033 pET22b(+) derivative containing the S. lividans protease spB ORF
obtained by PCR with the oligonucleotides VR017 and VR018. These
oligonucleotides incorporate a NdeI nd a XhoI restriction sites at the
ATG and C-terminus respectively to facilitate cloning in pET22b(+)
under T7 promoter control and with an in-frame poly-Histidine tag.
This Work
pVR034 pET22b(+) derivative containing the S. lividans protease spC ORF
obtained by PCR with the oligonucleotides VR019 and VR020. These
oligonucleotides incorporate a NdeI nd a XhoI restriction sites at the
ATG and C-terminus respectively to facilitate cloning in pET22b(+)
under T7 promoter control and with an in-frame poly-Histidine tag.
This Work
pVR047 pN702GEM3 derivative with the ORF corresponding to spB from
lividans under the control of xysA promoter and flanked by
transcriptional terminators (mmrt and fdt). The SpB protease is
produced with a poly-Histidine tag at the C-terminus.
This Work
pVR048 pN702GEM3 derivative with the ORF corresponding to spC from
lividans under the control of xysA promoter and flanked by
transcriptional terminators (mmrt and fdt). The SpC protease is
produced with a poly-Histidine tag at the C-terminus.
This Work
pVR052 pN702GEM3 derivative. It contains a the lpIgene for the S. lividans
subtilisin-like inhibitor (SLPI) expressed from the xysA promoter. The
gene was amplified with oligonucleotides flanking the RBS and
coding region of the gene and put under the control of xysA p moter,
flanked by transcriptional terminators (mmrt and fdt).
This Work
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